Kevin V King

Title: Kevin V King: Innovator in HIV Research

Introduction

Kevin V King is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of HIV research, particularly in the area of co-receptor tropism detection. With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of HIV-infected patients.

Latest Patents

Kevin V King's latest patents focus on methods for detecting HIV-1 co-receptor tropism. The first patent describes a method that includes preparing an HIV-1 envelope protein coding sequence from a sample. It involves introducing this coding sequence into a first expression construct using yeast homologous recombination. This construct is then utilized in a cell-to-cell fusion assay to determine HIV-1 co-receptor tropism. The second patent outlines a similar method, where a plasmid expression vector containing a near-full length HIV-1 genome is modified to replace a yeast uracil biosynthesis gene with the HIV-1 envelope protein coding sequence prepared from the patient sample. This innovative approach also aims to determine HIV-1 co-receptor tropism through a cell-to-cell fusion assay.

Career Highlights

Kevin V King is affiliated with Case Western Reserve University, where he continues to advance his research in HIV. His work is characterized by a commitment to improving patient outcomes through innovative methodologies.

Collaborations

Some of his notable coworkers include Eric J Arts and Alison Laing Wright. Their collaborative efforts contribute to the ongoing research and development in the field of HIV.

Conclusion

Kevin V King stands out as an influential inventor in HIV research, with his patents paving the way for advancements in understanding and treating the virus. His contributions are vital to the ongoing fight against HIV, showcasing the importance of innovation in medical science.